Takara Bio USA, Inc., previously known as Clontech Laboratories, Inc., is a prominent player in the Biotechnology sector. Established in 1984, the company has a longstanding presence in the industry. Headquartered in the United States, its mission is encapsulated in its slogan: "Empowering gene and cell therapy with comprehensive manufacturing and customer services."
Takara Bio USA offers an extensive array of life science reagents through well-regarded brands like Takara®, Cellartis®, and Clontech®. Their products facilitate crucial applications, including stem cell research, next-generation sequencing (NGS), and gene editing.
Despite its comprehensive offerings and longstanding market presence, the company has not disclosed any recent investment activity or involvement from investors, which might suggest financial independence or a strategic focus on organic growth. For investors, Takara Bio USA's deep expertise and established brand could represent a robust opportunity in the rapidly evolving biotech landscape.